This guide will help you understand how HCM presents in children and how to support your child through diagnosis and treatment.

That bodes well for aficamten, which is playing catch-up with Camzyos (mavacamten), currently the only FDA-approved treatment for obstructive HCM. BMS' drug was launched in 2022 and saw sales more ...

Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to ...

The doctor may use an electrocardiogram (EKG) to detect and characterize bradycardia. This test measures the electrical signals that pass through your heart using several small sensors attached to ...

The purpose of this study was to evaluate whether the 12-lead ECG could be substituted by ECG sets with a limited number of leads. Materials and methods: The performance of three ECG systems (ie ...

Hypertrophic cardiomyopathy (HCM) isn’t just a condition that affects adults—it can also be diagnosed in children, including infants. For parents, hearing that their child has a heart condition can be ...